Zydus Lifesciences has informed that it enclosed a copy of press release dated October 30, 2023 titled ‘Zydus and Sun Pharma sign licensing agreement for co-marketing of Desidustat, a critical treatment for chronic kidney disease patients in India’.
The above information is a part of company’s filings submitted to BSE.